Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
Silvan Tuerkcan Reiterated (TERN) at Buy and Held Target at $17 on, Mar 29th, 2023
Silvan Tuerkcan of JMP Securities, Reiterated "Terns Pharmaceuticals, Inc." (TERN) at Buy and Held Target at $17 on, Mar 29th, 2023.
Silvan has made no other calls on TERN in the last 4 months.
There are 2 other peers that have a rating on TERN. Out of the 2 peers that are also analyzing TERN, 0 agree with Silvan's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Silvan
- Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $19 on, Tuesday, February 7th, 2023
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $14 on, Tuesday, December 20th, 2022
